a public good project by the
Synthesis
Company
of California

© 2026

G. Lelli | doi.page

0 works0 citations0 h-index

G. Lelli

University of Michigan(US)

Publications by Year

Research Areas

Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Gastric Cancer Management and Outcomes

Most-Cited Works

→ A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours(2005)285 cited
→ Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation(2013)230 cited
→ Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara®) in breast cancer patients(2001)98 cited
→ Transitional Cell Carcinoma of the Upper Urinary Tract: Evaluation of Prognostic Factors by Histopathology and Flow Cytometric Analysis(1991)87 cited
→ Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients(2010)62 cited
→ Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer(2001)45 cited

→ Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)(2006)

45 cited

→ A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer(2004)38 cited

→ Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer(1998)35 cited

→ Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients(2010)22 cited